INITIAL RESULTS OF ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION FOR BENIGN THYROID NODULES AT BINH DUONG GENERAL HOSPITAL

Anh Vũ Phạm 1, , Thị Thùy Dung Lê 2
1 Binh Duong General Hospital
2 Institute of Medical and Pharmaceutical Training, Thu Dau Mot University

Main Article Content

Abstract

Background: Radiofrequency ablation (RFA) is a minimally invasive treatment that has been increasingly applied in the management of benign thyroid nodules. However, data regarding its effectiveness and safety in provincial hospitals in Vietnam remain limited. Objectives and Methods: A prospective, descriptive, single-arm interventional study was conducted on 37 patients with 41 benign thyroid nodules (Bethesda II) treated with ultrasound-guided RFA at Binh Duong General Hospital from June 2024 to June 2025. Evaluated parameters included symptom score, cosmetic score, nodule volume, volume reduction ratio (VRR), pain severity, and complications at baseline, 1 month, and 3 months after treatment. Results: After RFA, the median symptom score decreased from 4 at baseline to 2 at 1 month and remained unchanged at 3 months (p < 0.01). The cosmetic score significantly improved from 4 to 1 at 3 months (p < 0.01). Median nodule volume decreased from 7.76 ml to 4.51 ml at 1 month and to 2.88 ml at 3 months, with median VRRs of 29.6% and 46.6%, respectively. Most patients reported mild to moderate pain. No complications were observed in 90.3% of cases, and recorded complications were mild and transient. Conclusions: Radiofrequency ablation is an effective, safe, and minimally invasive treatment for benign thyroid nodules and is feasible for implementation in provincial hospital settings.

Article Details

References

1. Gharib H, Papini E, Garber JR, et al. AACE/AME/ACE medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2016;22(Suppl 1):1–60.
2. Papini E, Monpeyssen H, Frasoldati A, Hegedüs L. European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J. 2020;9:172–185.
3. Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation. AJR Am J Roentgenol. 2010;194:1137–1142.
4. Cesareo R, Pasqualini V, Simeoni C, et al. Effectiveness of ultrasound-guided radiofrequency ablation in benign thyroid nodules. J Clin Endocrinol Metab. 2015;100:460–466.
5. Kim JH, Baek JH, Lim HK, et al. 2017 thyroid radiofrequency ablation guideline. Korean J Radiol. 2018;19:632–655.
6. Monpeyssen H, Alamri A, Ben Hamou A. Long-term results of ultrasound-guided radiofrequency ablation of benign thyroid nodules. Front Endocrinol. 2021;12:638880.
7. Huỳnh Quang Khánh, Vũ Hữu Vĩnh, Nguyễn Văn Khôi, và cộng sự. Kết quả đốt nhân giáp lành tính bằng sóng cao tần. Y Học TP. Hồ Chí Minh. 2018;22(5):195–202.
8. Phạm Thế Đức, Nguyễn Khắc Hoàng, Đỗ Văn Quyền và cộng sự. Đánh giá kết quả bước đầu áp dụng RFA điều trị bướu giáp nhân lành tính tại Bệnh viện Trung ương Quân đội 108. J 108 Clin Med Pharm. 2020;15(2).88-94
9. Hussain I, Zulfiqar F, Li X, Ahmad S, Aljammal J. Safety and Efficacy of Radiofrequency Ablation of Thyroid Nodules-Expanding Treatment Options in the United States. J Endocr Soc. 2021 Aug;5(8):bvab110. doi:10.1210/jendso/bvab110